Xanthus Pharmaceuticals, Inc. Report issue

For profit Phase 2
Founded: Cambridge MA United States (2001)
Status: Acquired by Antisoma Research (2008)

Organization Overview

First Clinical Trial
2004
NCT00087854
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Xanthus Life Sciences-Medical Monitor